Delineating neck targets for intensity-modulated radiation therapy of head and neck cancer

Frontiers of Radiation Therapy and Oncology

Volumn 40, Issue , 2007, Pages 193-207

  David, M B ^a   Eisbruch, A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HEAD AND NECK TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; METHODOLOGY; RADIATION DOSE; TUMOR RECURRENCE; WOUND DRAINAGE;

DRAINAGE; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547515991     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000106036     Document Type: Conference Paper

References (38)

1. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA: Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704.
2. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A: Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57:61-70.
3. Eisbruch A, Schwartz M, Rasch C, et al: Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60: 1425-1439.
4. Fung K, Lyden TH, Lee J, et al: Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005;63:1395-1399.
5. Som PM: The present controversy over the imaging method of choice for evaluating the soft tissues of the neck. AJNR Am J Neuroradiol 1997; 18:1869-1872.
6. Schechter NR, Gillenwater AM, Byers RM, et al: Can positron emission tomography improve the quality of care for head-and-neck cancer patients? Int J Radiat Oncol Biol Phys 2001;51:4-9.
7. Daisne JF, Duprez T, Weynand B, et al: Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004;233:93-100.
8. Kubota K, Yokoyama J, Yamaguchi K, et al: FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590-595.
9. Anzai Y, Minoshima S, Wolf GT, Wahl RL: Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET. Radiology 1999;212: 285-290.
10. Lapela M, Grenman R, Kurki T, et al: Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
11. van den Brekel MW, Stel HV, Castelijns JA, et al: Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379-384.
12. Eisbruch A,Foote RL, O'SulIivan B, Beitler JJ, Vikram B: Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002;12:238-249.
13. Rouvière H: Lymphatic System of the Head and Neck (translated by Tobias M). Ann Arbor, Edward Brothers, 1938.
14. Mukherji SK, Armao D, Joshi VM.: Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect. Head Neck 2001; 23:995-1005.
15. Lindberg R: Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446-1449.
16. Byers RM, WoIf PF, Ballantyne AJ: Rationale for elective modified neck dissection. Head Neck Surg 1988;10:160-167.
17. Candela FC, Shah J, Jaques DP, Shah JP: Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg 1990;116:432-435.
18. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW: Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601-605.
19. Robbins KT: Integrating radiological criteria into the classification of cervical lymph node disease. Arch Otolaryngol Head Neck Surg 1999;125: 385-387.
20. Som PM, Curtin HD, Mancuso AA: An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg 1999;125:388-396.
21. Gregoire V, Coche E, Cosnard G, Hamoir M, Reychler H: Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000;56:135-150.
22. Nowak PJ, Wijers OB, Lagerwaard FJ, Levendag PC: A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radial Oncol Biol Phys 1999;45:33-39.
23. Wijers OB, Levendag PC, Tan T, et al: A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol 1.999; 52:35-42.
24. Million RR CN: Management of Head and Neck Cancer: A Multidisciplinary Approach, ed 2. Philadelphia, Lippincott, 1994.
25. Eisbruch A, Marsh LH, Dawson LA, et al: Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004;59:28-42.
26. Dawson LA, Anzai Y, Marsh L, et al: Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000;46:1117-1126.
27. King AD, Ahuja AT, Leung SF, et al: Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000; 22:275-281.
28. McLaughlin MP, Mendenhall WM, Mancuso AA, et al: Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck. Head Neck 1995;17:190-198.
29. http://www.rtog.org/hnatlas/main.html.
30. Hasegawa Y, Matsuura H: Retropharyngeal node dissection in cancer of the oropharynx and hypopharynx. Head Neck 1994;16:173-180.
31. Ballantyne AJ: Significance of retropharyngeal nodes in cancer of the head and neck. Am J Surg 1964;108:500-504.
32. Amatsu M, Mohri M, Kinishi M: Significance of retropharyngeal node dissection at radical surgery for carcinoma of the hypopharynx and cervical esophagus. Laryngoscope 2001;111:1099-1103.
33. Fisch U: Lymphography of the Cervical Lymphatic System, Philadelphia, Saunders, 1968.
34. de Arruda FF, Puri DR, Zhung J, et al: Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006;64:363-373.
35. Yao M, Dornfeld KJ, Buatti JM, et al: Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005;63:410-421.
36. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA: Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;55:312-321.
37. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM.: Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on. target volume delineation. Int J Radiat Oncol Biol Phys 2003;57:49-60.
38. http://www.rtog.org/members/protocols/0225/0225.pdf.